Japan

The Japanese government is aware of the challenges in securing funds for drug development within Japan’s biopharmaceutical startup ecosystem, especially compared to Europe and the United States. The Japan Agency for Medical Research and Development has established a program to support biopharmaceutical startups involved in developing patentable pharmaceuticals and regenerative medicine products and therapeutics.
Continue Reading Japan’s AMED Offers ‘Double Match Up’ Grants for Pharma Startups: Considerations for Investors and Companies

On June 13, 2025, Japan’s government approved the Basic Policy on Economic and Fiscal Management and Reform 2025, signaling a strong commitment to advancing its space policy and fostering the development of space-related businesses. This pivotal document sets out the government’s main priorities and paves the way for next year’s budget decisions.
Continue Reading Japan’s Basic Policy 2025 Strengthens Space Industry